Could the end of blockbuster drugs be a reality? Back in the 1990’s we saw many new drugs come to the market that seemed to be created to be mass-marketed directly to the public – in spite of the fact that they were prescription...
Read MoreCongratulations to Susan Desmond-Hellman, former president for Genentech’s product development, on being nominated for a seat as chancellor of the University of California at San Francisco (UCSF). Ms. Desmond-Hellman is a 51...
Read MoreSenator Charles E. Grassley of Iowa may leave the Senate Committee on Finance in order to take the top republican spot at the Senate Judiciary Committee, according to rumors that transcended last week. Mr. Grassley has been a...
Read MoreCrisis brings change. It is during times like these, of general economic duress, that one can see this in motion and experience its consequences. Pharmaceutical companies are experiencing perhaps the toughest times in many years...
Read MoreAccording to a study by PriceWaterHouseCoopers’ Health Research Institute on the Top Nine Health Industry Issues for 2009, the cost of genetic testing is dropping to levels that will allow companies to offer these services to...
Read More
Testimonial
Smart Pharmaceutical Consulting has made a major contribution to our manufacturing strategy and how we plan to operate our plant in the future.